EBAA
We restore sight worldwide
The Policy & Position Review Subcommittee (PPRS) of the EBAA Medical Advisory Board continues to review its guidance and screening recommendations regarding COVID-19. Given that COVID-19 is now endemic in […]
EBAA submitted comments to FDA last week on recent guidances that address HCT/P donor eligibility and recommendations to reduce the risk of HIV, hepatitis B virus and hepatitis C virus […]
February 3 is National Women Physicians Day. The date celebrates Elizabeth Blackwell’s birthday – the first female medical doctor in the U.S., and is a time to honor women doctors […]
The FDA has announced a revised implementation date of May 4, 2025, for its recently issued guidance documents: While the guidance documents remain final, FDA’s decision to delay implementation reflects a […]
Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by HCT/Ps Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, […]
FDA released four draft and two final tissue guidances on January 6, 2025, for donors of human cells, tissues, and cellular and tissue-based products (HCT/Ps). EBAA will be hard at […]
Release of Updated Uniform DRAI Forms A fully updated Birth Mother Uniform Donor Risk Assessment Interview (DRAI) has been released for use when the donor is less than 18 months […]
During this season of gratitude and reflection, the EBAA staff sends our deepest appreciation to you for your ongoing dedication to the restoration of sight worldwide! As you celebrate the […]
360 Partners enjoy year-round access to EBAA members
